Literature DB >> 20683254

N-acetylcysteine protects against bupivacaine-induced myotoxicity caused by oxidative and sarcoplasmic reticulum stress in human skeletal myotubes.

Olivier Galbes1, Annick Bourret, Karine Nouette-Gaulain, Fabien Pillard, Stefan Matecki, Guillaume Py, Jacques Mercier, Xavier Capdevila, Alexandre Philips.   

Abstract

BACKGROUND: Local anesthetics offer the benefits of extended analgesia with greater patient satisfaction and faster rehabilitation compared with intravenous morphine. These benefits, however, can be offset by adverse iatrogenic muscle pain. Here, the authors investigate the mechanisms of local anesthetic-induced myotoxicity and assess the protective effect of N-acetylcysteine.
METHODS: The authors used primary cell cultures of human skeletal muscle myoblasts to study local anesthetic adverse effects. Production of reactive oxygen species was investigated in human skeletal myotubes by fluorescence microscopy. Expression of sarcoplasmic/endoplasmic reticulum stress markers and induction of apoptosis were followed by immunofluorescence and Western blot analysis. Finally, the effect of N-acetylcysteine on bupivacaine-induced myotoxicity was investigated in vitro.
RESULTS: Bupivacaine sequentially induced reactive oxygen species production, oxidative stress, sarcoplasmic/endoplasmic reticulum stress, and activation of caspases 9 and 7 in human differentiated myoblasts. These iatrogenic effects were prevented by N-acetylcysteine.
CONCLUSIONS: The authors demonstrated a protective effect of N-acetylcysteine against bupivacaine-induced sarcoplasmic/endoplasmic reticulum stress and apoptosis in primary human skeletal muscle cell.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20683254     DOI: 10.1097/ALN.0b013e3181e4f4ec

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  7 in total

1.  Bupivacaine Induces ROS-Dependent Autophagic Damage in DRG Neurons via TUG1/mTOR in a High-Glucose Environment.

Authors:  Luying Lai; Yongwei Wang; Shenghui Peng; Wenjing Guo; Guanshan Wei; Le Li; Zhengyuan Xia; Fengxian Li; Shiyuan Xu
Journal:  Neurotox Res       Date:  2022-01-18       Impact factor: 3.911

2.  ROS-mediated lysosomal membrane permeabilization is involved in bupivacaine-induced death of rabbit intervertebral disc cells.

Authors:  Xianyi Cai; Yunlu Liu; Yiqiang Hu; Xianzhe Liu; Hongyan Jiang; Shuhua Yang; Zengwu Shao; Yun Xia; Liming Xiong
Journal:  Redox Biol       Date:  2018-06-27       Impact factor: 11.799

3.  Monosialoganglioside protects against bupivacaine-induced neurotoxicity caused by endoplasmic reticulum stress in rats.

Authors:  Benquan Liu; Jiemei Ji; Qing Feng; Xi Luo; Xiurong Yan; Yuxia Ni; Yajun He; Zhongxuan Mao; Jingchen Liu
Journal:  Drug Des Devel Ther       Date:  2019-02-19       Impact factor: 4.162

4.  Measurement of bupivacaine induced myotoxicity in interfascial plane blocks: A randomised controlled trial.

Authors:  Vasundhara Rakhi; Sonali Kaushal; Surinder Singh
Journal:  Indian J Anaesth       Date:  2021-12-22

5.  Alginate-liposomal construct for bupivacaine delivery and MSC function regulation.

Authors:  Mollie S Davis; Ileana Marrero-Berrios; Isabel Perez; Timothy Maguire; Palangat Radhakrishnan; Devasena Manchikalapati; Joseph SchianodiCola; Hattiyangangadi Kamath; Rene S Schloss; Joel Yarmush
Journal:  Drug Deliv Transl Res       Date:  2018-02       Impact factor: 4.617

6.  In vitro myotoxic effects of bupivacaine on rhabdomyosarcoma cells, immortalized and primary muscle cells.

Authors:  Thomas Metterlein; Petra Hoffmann; Ruth Späth; Michael Gruber; Bernhard M Graf; Wolfgang Zink
Journal:  Cancer Cell Int       Date:  2015-07-29       Impact factor: 5.722

Review 7.  Liposomal extended-release bupivacaine for postsurgical analgesia.

Authors:  Mark Lambrechts; Michael J O'Brien; Felix H Savoie; Zongbing You
Journal:  Patient Prefer Adherence       Date:  2013-09-06       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.